blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4111865

EP4111865 - ANTIBACTERIAL FORMULATION OF A MIXTURE OF BACTERIOPHAGES FOR USE IN PREVENTING OR TREATING DISEASES CAUSED BY SALMONELLA SPP. [Right-click to bookmark this link]
Former [2023/01]ANTIBACTERIAL FORMULATION MADE OF A MIXTURE OF BACTERIOPHAGES, USE THEREOF, AND METHOD FOR PREVENTING OR TREATING DISEASES CAUSED BY SALMONELLA SPP. IN BREEDING ANIMALS, BY ORALLY ADMINISTERING THE FORMULATION
[2023/11]
StatusNo opposition filed within time limit
Status updated on  08.03.2024
Database last updated on 03.01.2025
FormerThe patent has been granted
Status updated on  31.03.2023
FormerGrant of patent is intended
Status updated on  22.02.2023
FormerRequest for examination was made
Status updated on  02.12.2022
FormerThe international publication has been made
Status updated on  26.11.2022
Formerunknown
Status updated on  29.03.2022
Most recent event   Tooltip15.11.2024Lapse of the patent in a contracting state
New state(s): BG		published on 18.12.2024  [2024/51]
Applicant(s)For all designated states
Phagelab Chile SPA
Avenida Vicuña Mackenna 4860 Macul
Santiago / CL
[2023/18]
Former [2023/01]For all designated states
Phagelab Chile SPA
Avenida Vicuña Mackenna 4860
Macul, Santiago / CL
Inventor(s)01 / FERREIRA SOTO, Nicolas
Santiago 00000000 / CL
02 / CANAVAL ALFARO, Mauro
Santiago 00000000 / CL
03 / CIFUENTES PALMA, Pablo
Santiago 00000000 / CL
04 / TICHY NAVARRO, Daniel
Santiago 00000000 / CL
05 / ZAMUDIO CANAS, Maria Sofia
Santiago 00000000 / CL
06 / AGUILERA BARRIOS, Matias
Santiago 00000000 / CL
07 / PIZARRO BLACK, Trinidad
Vina del Mar 00000000 / CL
08 / SACRE RAVERA, Juan
Santiago 00000000 / CL
09 / PIERINGER CASTRO, Hans
Santiago 00000000 / CL
10 / PINO BARRIENTOS, Michael
Santiago 00000000 / CL
11 / NORAMBUENA VENEGAS, Rodrigo
Santiago 00000000 / CL
12 / CONTRERAS VERA, Francisca
Santiago 00000000 / CL
13 / ZAVALA PRATI, Angélica
Santiago 00000000 / CL
 [2023/01]
Representative(s)Clarke, Modet y Cía., S.L.
C/ Suero de Quiñones 34-36
28002 Madrid / ES
[N/P]
Former [2023/01]Clarke Modet & Co.
C/ Suero de Quiñones 34-36
28002 Madrid / ES
Application number, filing date21870473.219.05.2021
[2023/01]
WO2021CL50044
Filing languageES
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022241579
Date:24.11.2022
Language:ES
[2022/47]
Type: A1 Application with search report 
No.:EP4111865
Date:04.01.2023
Language:EN
[2023/01]
Type: B1 Patent specification 
No.:EP4111865
Date:03.05.2023
Language:EN
[2023/18]
Search report(s)International search report - published on:CL24.11.2022
(Supplementary) European search report - dispatched on:EP14.10.2022
ClassificationIPC:A01N63/40, A61K35/76, A61P31/04, C12N7/00, A01P1/00
[2023/01]
CPC:
A01N63/40 (EP,US); A61K35/76 (EP,US); A01P1/00 (EP,US);
A61P31/04 (US); C12N7/00 (EP); C12N2795/10121 (EP);
C12N2795/10132 (EP); C12N2795/10321 (EP); C12N2795/10332 (EP);
Y02A50/30 (EP) (-)
C-Set:
A01N63/40, A01N63/40 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/01]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ANTIBAKTERIELLE FORMULIERUNG AUS EINER MISCHUNG VON BAKTERIOPHAGEN ZUR VORBEUGUNG ODER BEHANDLUNG VON KRANKHEITEN, DIE DURCH SALMONELLA SPP. VERURSACHT WERDEN[2023/11]
English:ANTIBACTERIAL FORMULATION OF A MIXTURE OF BACTERIOPHAGES FOR USE IN PREVENTING OR TREATING DISEASES CAUSED BY SALMONELLA SPP.[2023/11]
French:COMPOSITION ANTIBACTÉRIENNE COMPOSÉE D'UN MÉLANGE DE BACTÉRIOPHAGES POUR PRÉVENIR OU TRAITER DES MALADIES PROVOQUÉES PAR SALMONELLA SPP.[2023/11]
Former [2023/01]ANTIBAKTERIELLE FORMULIERUNG AUS EINER MISCHUNG VON BAKTERIOPHAGEN, VERWENDUNG DAVON UND VERFAHREN ZUR VORBEUGUNG ODER BEHANDLUNG VON KRANKHEITEN, DIE DURCH SALMONELLA SPP. VERURSACHT WERDEN. IN DER TIERZUCHT, DURCH ORALE VERABREICHUNG DER FORMULIERUNG
Former [2023/01]ANTIBACTERIAL FORMULATION MADE OF A MIXTURE OF BACTERIOPHAGES, USE THEREOF, AND METHOD FOR PREVENTING OR TREATING DISEASES CAUSED BY SALMONELLA SPP. IN BREEDING ANIMALS, BY ORALLY ADMINISTERING THE FORMULATION
Former [2023/01]COMPOSITION ANTIBACTÉRIENNE COMPOSÉE D'UN MÉLANGE DE BACTÉRIOPHAGES; UTILISATION ET MÉTHODE POUR PRÉVENIR OU TRAITER DES MALADIES PROVOQUÉES PAR SALMONELLA.SPP CHEZ LES ANIMAUX D'ÉLEVAGE PAR L'ADMINISTRATION ORALE DE LA FORMULATION
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase04.05.2022Translation filed 
28.03.2022National basic fee paid 
28.03.2022Search fee paid 
28.03.2022Designation fee(s) paid 
28.03.2022Examination fee paid 
Examination procedure28.03.2022Examination requested  [2023/01]
29.11.2022Amendment by applicant (claims and/or description)
29.11.2022Date on which the examining division has become responsible
23.02.2023Communication of intention to grant the patent
21.03.2023Fee for grant paid
21.03.2023Fee for publishing/printing paid
21.03.2023Receipt of the translation of the claim(s)
Opposition(s)06.02.2024No opposition filed within time limit [2024/15]
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT03.05.2023
BG03.05.2023
CZ03.05.2023
DK03.05.2023
EE03.05.2023
ES03.05.2023
FI03.05.2023
HR03.05.2023
LT03.05.2023
LV03.05.2023
MC03.05.2023
NL03.05.2023
RO03.05.2023
RS03.05.2023
SE03.05.2023
SI03.05.2023
SK03.05.2023
SM03.05.2023
IE19.05.2023
LU19.05.2023
BE31.05.2023
NO03.08.2023
GR04.08.2023
IS03.09.2023
PT04.09.2023
[2024/51]
Former [2024/27]AT03.05.2023
CZ03.05.2023
DK03.05.2023
EE03.05.2023
ES03.05.2023
FI03.05.2023
HR03.05.2023
LT03.05.2023
LV03.05.2023
MC03.05.2023
NL03.05.2023
RO03.05.2023
RS03.05.2023
SE03.05.2023
SI03.05.2023
SK03.05.2023
SM03.05.2023
IE19.05.2023
LU19.05.2023
BE31.05.2023
NO03.08.2023
GR04.08.2023
IS03.09.2023
PT04.09.2023
Former [2024/21]AT03.05.2023
CZ03.05.2023
DK03.05.2023
EE03.05.2023
ES03.05.2023
FI03.05.2023
HR03.05.2023
LT03.05.2023
LV03.05.2023
MC03.05.2023
NL03.05.2023
RO03.05.2023
RS03.05.2023
SE03.05.2023
SK03.05.2023
SM03.05.2023
IE19.05.2023
LU19.05.2023
NO03.08.2023
GR04.08.2023
IS03.09.2023
PT04.09.2023
Former [2024/14]AT03.05.2023
CZ03.05.2023
DK03.05.2023
EE03.05.2023
ES03.05.2023
FI03.05.2023
HR03.05.2023
LT03.05.2023
LV03.05.2023
MC03.05.2023
NL03.05.2023
RO03.05.2023
RS03.05.2023
SE03.05.2023
SK03.05.2023
SM03.05.2023
LU19.05.2023
NO03.08.2023
GR04.08.2023
IS03.09.2023
PT04.09.2023
Former [2024/10]AT03.05.2023
CZ03.05.2023
DK03.05.2023
EE03.05.2023
ES03.05.2023
FI03.05.2023
HR03.05.2023
LT03.05.2023
LV03.05.2023
NL03.05.2023
RO03.05.2023
RS03.05.2023
SE03.05.2023
SK03.05.2023
SM03.05.2023
LU19.05.2023
NO03.08.2023
GR04.08.2023
IS03.09.2023
PT04.09.2023
Former [2024/08]AT03.05.2023
ES03.05.2023
FI03.05.2023
HR03.05.2023
LT03.05.2023
LV03.05.2023
NL03.05.2023
RS03.05.2023
SE03.05.2023
SK03.05.2023
SM03.05.2023
LU19.05.2023
NO03.08.2023
GR04.08.2023
IS03.09.2023
PT04.09.2023
Former [2024/03]AT03.05.2023
ES03.05.2023
FI03.05.2023
HR03.05.2023
LT03.05.2023
LV03.05.2023
NL03.05.2023
RS03.05.2023
SE03.05.2023
NO03.08.2023
GR04.08.2023
IS03.09.2023
PT04.09.2023
Former [2024/01]AT03.05.2023
ES03.05.2023
HR03.05.2023
LT03.05.2023
LV03.05.2023
NL03.05.2023
RS03.05.2023
SE03.05.2023
NO03.08.2023
GR04.08.2023
IS03.09.2023
PT04.09.2023
Former [2023/51]AT03.05.2023
ES03.05.2023
HR03.05.2023
NL03.05.2023
RS03.05.2023
SE03.05.2023
NO03.08.2023
GR04.08.2023
IS03.09.2023
PT04.09.2023
Former [2023/50]AT03.05.2023
ES03.05.2023
NL03.05.2023
SE03.05.2023
NO03.08.2023
GR04.08.2023
IS03.09.2023
PT04.09.2023
Former [2023/48]AT03.05.2023
ES03.05.2023
NL03.05.2023
SE03.05.2023
NO03.08.2023
PT04.09.2023
Former [2023/46]ES03.05.2023
PT04.09.2023
Cited inInternational search[A]EP2750519  (UNI AUTÒNOMA DE BARCELONA [ES]) [A] 0 * Todo el documento *;
 [A]JP6112961B  (SARAYA KK) [A] 0 * Todo el documento *;
 [A]  - LI, ZHIWEI et al., "A broad-spectrum phage controls multidrug-resistant Salmonella in liquid eggs", Food Research International, (20200000), vol. 132, doi:10.1016/j.foodres.2020.109011, page 109011, XP086142805 [A] 0 * . *

DOI:   http://dx.doi.org/10.1016/j.foodres.2020.109011
by applicantWO2010074388
 WO2013014273
 WO2017089947
 WO2019154032
    - JAMAL, M.BUKHARI, S. M.ANDLEEB, S.ALI, M.RAZA, S.NAWAZ, M. A.SHAH, S. S., "Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields", Journal of basic microbiology, (20190000), vol. 59, no. 2, pages 123 - 133
    - MAGIORAKOS, A. P.SRINIVASAN, A.CAREY, R. B.CARMELI, Y.FALAGAS, M. E.GISKE, C. G.MONNET, D. L., "Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance", Clinical microbiology and infection, (20120000), vol. 18, no. 3, pages 268 - 281
    - MODI, R.HIRVI, Y.HILL, A.GRIFFITHS, M. W., "Effect of phage on survival of Salmonella enteritidis during manufacture and storage of cheddar cheese made from raw and pasteurized milk", Journal of food protection, (20010000), vol. 64, no. 7, pages 927 - 933
    - PHILIPSON, C. W.VOEGTLY, L. J.LUEDER, M. R.LONG, K. A.RICE, G. K.FREY, K. G.BISHOP-LILLY, K. A., "Characterizing phage genomes for therapeutic applications", Viruses, (20180000), vol. 10, no. 4, page 188
    - WHICHARD, J. M.SRIRANGANATHAN, N.PIERSON, F. W., "Suppression of Salmonella growth by wild-type and large-plaque variants of bacteriophage Felix 01 in liquid culture and on chicken frankfurters", Journal of food protection, (20030000), vol. 66, no. 2, pages 220 - 225, XP009164630
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.